Don't wait a day or two to get back to me on this, or

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks Goosebumps #97215
203
Don't wait a day or two to get back to me on this, or Krugman will become completely wrong RE every single point he makes.

That's how it work here on the Rabbit Hole Board.



Will 2024 Be a Vaccine Election?

Dec. 15, 2022

https://www.nytimes.com/2022/12/15/opinion/ro...ction.html


Credit...Scott McIntyre for The New York Times

By Paul Krugman
Opinion Columnist

Will Republicans once again nominate Donald Trump for president? Or will they turn to Ron DeSantis instead? I have no idea.

What I do know is that anyone imagining DeSantis as a more sensible, saner figure than Trump — a right-wing populist without the reality-denying paranoia — is delusional. DeSantis hasn’t gone down all the same rabbit holes as Trump, but he has gone down some of his own, and his descent has been just as deep.

Above all, DeSantis is increasingly making himself the face of vaccine conspiracy theories, which have turned a medical miracle into a source of bitter partisan division and have contributed to thousands of unnecessary deaths.

Let’s back up and talk about the story of Covid-19 vaccines so far.

In the spring of 2020 the U.S. government initiated Operation Warp Speed, a public-private partnership intended to develop effective vaccines against the coronavirus as quickly as possible. The effort succeeded: By December 2020, far sooner than almost anyone had imagined possible, vaccinations were underway. (I received my first shot the next month, on Jan. 28, 2021.) And yes, this was a success for the Trump administration.

Have the vaccines worked? And how. There are multiple ways to evaluate their lifesaving effect, but I’m especially taken with a simple approach promoted by the analyst Charles Gaba, who looks at the correlation across U.S. counties between vaccination rates and Covid death rates.

Between May 2021, when two-dose vaccinations first became widespread, and September 2022 the least-vaccinated 10 percent of counties suffered a death rate more than three times as high as the most-vaccinated.

Now, you may have heard that at this point deaths among vaccinated Americans are exceeding those among the unvaccinated, which is true. But that’s partly because most deaths are among the elderly, who are overwhelmingly vaccinated; very few Americans have received no shots; and not enough vaccinated people are getting booster shots.

But why are some U.S. counties so much less vaccinated than others? The answer, as Gaba shows, is partisanship: There’s a startlingly close relationship between the share of a county’s voters who supported Trump in 2020 and the percentage of that county’s residents who haven’t received their shots — and the percentage who have died from Covid.

You can, by the way, see the same patterns at the level of whole states. For example, although New York was hit hard in the first months of the pandemic (before we knew how the coronavirus spread or what precautions to take), since May 2021 more than twice as many people have died of Covid in Florida than in New York. Even taking Florida’s slightly larger and much older population into account, that’s thousands of excess deaths in the Sunshine State.

Yet why should vaccination be a partisan issue?

Right-wing opposition to lockdowns and social distancing in the early stages of the pandemic made at least some sense, since these public health measures involved requiring that people make some sacrifices to protect other people’s lives. (Some might say that such trade-offs are what civilization is all about, but whatever.) Even mask mandates required accepting a bit of inconvenience, at least partly for the sake of others.

But getting vaccinated is mainly about protecting yourself. Why wouldn’t you want to do that?
The immediate answer is the widespread belief on the right that the vaccines have terrible side effects. This belief is hard to justify: If it were true, shouldn’t there be a lot of evidence for such claims, given that more than 13 billion doses have been administered worldwide?

Ah, but the usual suspects claim that sinister elites are suppressing the evidence. Which brings us back to DeSantis, who announced on Tuesday that he was forming a state committee to counter federal health policy recommendations — and asking for a grand jury investigation into unspecified “crimes and misdemeanors” related to coronavirus vaccines.

OK, I doubt that anyone believes that DeSantis knows or cares about the scientific evidence here. What he’s doing instead is catering to a Republican base that equates listening to experts, on public health or anything else, with “wokeness,” and demonizes anyone saying things it doesn’t want to hear.

As far as I can tell, DeSantis hasn’t joined the likes of Elon Musk in calling for the prosecution of Anthony Fauci, who led America’s Covid response. But he has called Fauci a “little elf” and said that we should “chuck him across the Potomac.” (Presidential!)

Now, will DeSantis’s attempt to position himself as the leader of the anti-vax movement and give at least tacit approval to conspiracy theories actually endear him to the Republican base? Again, I don’t know.

Even if it does, I suspect that it will hurt him in the general election if he does become the nominee: Vaccine paranoia and Fauci hatred are still niche positions in the electorate at large.

But anyone who imagines that replacing Trump with DeSantis as the G.O.P.’s leader would signal a party on its way to becoming sane again is in for a rude shock.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 6

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 4

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 8

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 6

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 7

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 5

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 8

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
Anecdotes by Artists Brings Raw Scent Stories to Sephora

Updated Category News Views 3

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 5

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading

Top 5 Most Recently Viewed Articles

Amendments Approved by Baltic Horizon Fund Bondholders

Updated Category News Views 189

Key Amendments Approved for Baltic Horizon Fund Bonds Baltic Horizon Fund sought the approval of its bondholders for several amendments related to its EUR 42 million floating rate bonds set to mature in 2028. This written procedure occurred recently, allowing bondholders to engage in crucial decisions regarding the terms governing their investments. Voting Procedures and...

Continue Reading
Xnurta: Reinventing AI-Powered Advertising Solutions

Updated Category News Views 641

Xnurta: A New Era in AI-Powered Advertising Xnurta, previously known as Xmars, has been at the forefront of innovation in AI-driven ad management solutions. By rebranding, Xnurta not only changes its name but also signifies a transformative journey into the future of advertising alongside AI advancements. A Shift Towards Agentic AI This rebranding mirrors the exciting...

Continue Reading
Harrow Health's Bright Future: Innovations Driving Performance

Updated Category News Views 156

Harrow Health's Promising Innovations and Growth Strategy Harrow Health has recently caught the attention of financial analysts with an optimistic forecast from B. Riley. The financial services firm has raised its price target on Harrow Health (NASDAQ: HROW) shares to an impressive $73.00, significantly increasing it from the previous $50.00. Holding a Buy rating, B....

Continue Reading
F&G Annuities & Life Increases Dividend to $0.25 per Share

Updated Category News Views 132

F&G Annuities & Life Raises Common Stock Dividend Significantly F&G Annuities & Life, Inc. (NYSE: FG) has made an exciting announcement regarding their quarterly common stock dividend. The company revealed a remarkable 14% increase, moving from $0.22 to $0.25 per common share. This increase reflects the company’s strong performance and commitment to providing value to...

Continue Reading
MicroStrategy's Slight Recovery Sparks Hope for Bitcoin Growth

Updated Category News Views 107

MicroStrategy's Resilient Recovery After Market Setbacks MicroStrategy has recently made headlines with its remarkable recovery after a significant 16% drop in the market. This rebound raises an important question: Can a Bitcoin price surge to $100,000 continue to drive financial growth for companies invested in cryptocurrencies, especially MicroStrategy, a prominent...

Continue Reading